Evidence map›Paper›PMID 42502462›Full record

ArticleJAAD international2026

International expert consensus on transdermal drug delivery technologies in dermatology.

Jinjin Zhu, Yan Li, Xiuli Wang, Leihong Xiang, Martin Röcken, Vincent Piguet, Shyam Verma, Diamant Thaçi, Chunying Li, Xiang Chen and 25 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JAAD international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors.

Jinjin ZhuDepartment of Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Yan LiDepartment of Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Xiuli WangInstitute of Photomedicine, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, China.
Leihong XiangDepartment of Dermatology, Huashan Hospital, Fudan University, Shanghai, China.
Martin RöckenDepartment of Dermatology, Eberhard Karls University Tübingen, Tübingen, Germany.
Vincent PiguetWomen's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada.
Shyam VermaNirvan Skin Clinic, Vadodara, India.
Diamant ThaçiInstitute and Comprehensive Center for Inflammation Medicine, University of Lübeck, Lübeck, Germany.
Chunying LiDepartment of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Xiang ChenDepartment of Dermatology, Xiangya Hospital, Central South University, Changsha, China.
Mingji ZhuDepartment of Dermatology, China-Japan Union Hospital of Jilin University, Changchun, China.
Xiaoping MiaoDepartment of Epidemiology and Biostatistics, School of Public Health, TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan, China.
Honglin WangShanghai Institute of Immunology, Translational Medicine Center, Shanghai General Hospital, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Cheng ZhouDepartment of Dermatology, Peking University People's Hospital, Beijing, China.
Yan DingDepartment of Dermatology, Hainan Provincial Hospital of Skin Disease, Haikou, China.
Jun XieDepartment of Dermatology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Yuling ShiDepartment of Dermatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China.
Mitchel P GoldmanCosmetic Laser Dermatology, A Platinum Dermatology Partners Company, San Diego, California.
Fei HaoDepartment of Dermatology, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Qiri MuDepartment of Dermatology, International Mongolian Hospital of Inner Mongolia, Hohhot, China.
Xiaoyong ManDepartment of Dermatology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Wen-Hung ChungDepartment of Dermatology, Xiamen Chang Gung Hospital, Xiamen, China.
Xue WangDepartment of Dermatology, First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi, China.
Rong XiaoDepartment of Dermatology, Second Xiangya Hospital, Central South University, Changsha, China.
Nan YuDepartment of Dermatology, General Hospital of Ningxia Medical University, Yinchuan, China.
Aijun ChenDepartment of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Jintao ZhuHubei Key Laboratory of Bioinorganic Chemistry and Materia Medica, Wuhan, China.
Yong CuiDepartment of Dermatology, China-Japan Friendship Hospital, Beijing, China.
Lin MaDepartment of Dermatology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Ping YinDepartment of Epidemiology and Health Statistics, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Wenbo BuInstitute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China.
Liu YangDepartment of Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Jun LiDepartment of Dermatology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Xinghua GaoDepartment of Dermatology, The First Hospital of China Medical University, Shenyang, China.
Juan TaoDepartment of Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Transdermal drug delivery technologies (TDDTs) enhance drug absorption and therapeutic outcomes in dermatology, yet standardized, evidence-based recommendations for their clinical application remain lacking. Objective: To provide expert consensus recommendations on the clinical application of TDDTs, with a focus on fractional lasers and microneedles. Methods: A multidisciplinary panel of 25 experts systematically reviewed current literature and clinical practices. The consensus was developed using the Grading of Recommendations Assessment, Development and Evaluation framework to assess evidence quality and recommendation strength and the modified Delphi method to achieve expert agreement. Results: Evidence-based recommendations were formulated for the use of TDDTs in a variety of dermatological conditions, including cutaneous malignancies and precancerous lesions, viral warts, inflammatory and autoimmune skin diseases, and cosmetic indications. Conclusion: Fractional lasers and microneedles are valuable transdermal delivery tools for dermatological therapy. This expert consensus provides practical, evidence-based guidance to support their safe and effective clinical use.

Indexed as

evidence-based medicinefractional laserGRADEmicroneedlingmodified Delphi methodtransdermal drug delivery

Identifiers

PMID42502462
PMCPMC13400427

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.